Multidrug resistance and the role of P-glycoprotein knockout mice.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Cancer

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0959-8049(95)00130-BPMID 7577039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in Drug-selected and Transfected Human Tumor Cells

  1995cited by this paper
• Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.

  1995cited by this paper
• The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.

  1994cited by this paper
• Clinical reversal of the multidrug resistance phenotype: true tumour modulation or pharmacokinetic interaction?

  1994cited by this paper
• ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

  1994cited by this paper
• Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

  1994cited by this paper
• P-glycoprotein expression and function in circulating blood cells from normal volunteers.

  1994cited by this paper
• Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

  1993cited by this paper
• Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells.

  1993cited by this paper
• Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals.

  1993cited by this paper
• Human P-glycoprotein transports cyclosporin A and FK506.

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Modulation of multidrug resistance: at the threshold.

  1993cited by this paper
• Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

  1992cited by this paper
• Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

  1992cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cited by this paper
• In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.

  1991cited by this paper
• P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma.

  1991cited by this paper
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cited by this paper
• Pharmacology of drugs that alter multidrug resistance in cancer.

  1990cited by this paper
• Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas

  1990cited by this paper
• Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities

  1990cited by this paper
• The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

  1989cited by this paper
• Expression of Multidrug Resistance Gene in Human Cancers

  1989cited by this paper
• Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.

  1989cited by this paper
• Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

  1989cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper

• Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs

  2025cites this paper
• Recent advances on the application of nanobiomimetic structures as drug delivery systems

  2024cites this paper
• Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS

  2023cites this paper
• Experimental and computational models to investigate intestinal drug permeability and metabolism

  2023cites this paper
• Chemogenetics for cell-type-specific modulation of signalling and neuronal activity

  2023cites this paper
• Cell Surface Transporters and Novel Drug Developments

  2022cites this paper
• Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1‐deficient collie dogs

  2022influential citation
• Simple and efficient protocol to isolate and culture brain microvascular endothelial cells from newborn mice

  2022cites this paper
• Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo

  2022cites this paper
• The Use of Propolis in Dentistry, Oral Health, and Medicine: A Review.

  2021cites this paper
• The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors

  2021cites this paper
• Flavonoid-Mediated Modulation of CYP3A Enzyme and P-Glycoprotein Transporter: Potential Effects on Bioavailability and Disposition of Tyrosine Kinase Inhibitors

  2020cites this paper
• Calculation of an Apical Efflux Ratio from P-Glycoprotein (P-gp) In Vitro Transport Experiments Shows an Improved Correlation with In Vivo Cerebrospinal Fluid Measurements in Rats: Impact on P-gp Screening and Compound Optimization

  2020influential citation
• Effects of cholesterol content on activity of P-glycoproteins and membrane physical state, and consequences for anthelmintic resistance in the nematode Haemonchus contortus

  2020cites this paper
• Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.

  2019cites this paper
• Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

  2018cites this paper
• Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters

  2018cites this paper
• Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access

  2017cites this paper
• Personalisation of dexamethasone in childhood acute lymphoblastic leukaemia

  2017cites this paper
• Abcb1a but not Abcg2 played a predominant role in limiting the brain distribution of Huperzine A in mice.

  2017cites this paper
• Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells

  2016cites this paper
• ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice

  2016cites this paper
• Modelling the transport of nanoparticles across the blood-brain barrier using an agent-based approach

  2016cites this paper
• CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? −inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration

  2016cites this paper
• Gaining Insights Into the Pharmacology of Anthelmintics Using Haemonchus contortus as a Model Nematode.

  2016cites this paper
• Xanthone analogues as potent modulators of intestinal P-glycoprotein.

  2015cites this paper
• Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood-CSF barrier during development in the nonhuman primate (P. hamadryas).

  2015cites this paper
• ATP-binding cassette transporters in reproduction: a new frontier.

  2015cites this paper
• Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis.

  2015cites this paper
• Mechanisms of the anti-proliferative actions of the schweinfurthins in cancer cells

  2015cites this paper
• A dverse Drug Reactions in Herding-Breed Dogs : T he Role of P-Giycoprotein *

  2015cites this paper
• Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin

  2015cites this paper
• Diagnosing Biopharmaceutical Limitations

  2015cites this paper
• Characterization of ATP-binding Cassette Transporter Genes in Silkworm, Bombyx Mori

  2015cites this paper
• Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.

  2014cites this paper
• Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

  2014cites this paper
• A Generator-Produced Gallium-68 Radiopharmaceutical for PET Imaging of Myocardial Perfusion

  2014cites this paper
• ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

  2014cites this paper
• Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance

  2014cites this paper
• Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations

  2014cites this paper
• P-glycoprotein (P-gp/MDR1)/ABCB1

  2013cites this paper
• Frequency Evaluation of C3435T Polymorphism of the MDR1 Gene in a Healthy Population in Mazandaran Province

  2013cites this paper
• Evaluation of Breast Cancer Resistance Protein Function in Hepatobiliary and Renal Excretion Using PET with 11C-SC-62807

  2013cites this paper
• Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

  2013cites this paper
• UNIVERSIDADE FEDERAL DA PARAÍBA CENTRO DE CIÊNCIAS EXATAS E DA NATUREZA PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR

  2013cites this paper
• Transporter study methodologies

  2013cites this paper
• Moxidectin has a lower neurotoxic potential but comparable brain penetration in P-glycoprotein-deficient CF-1 mice compared to ivermectin.

  2013cites this paper
• The role of multidrug resistance‐associated protein in the blood–brain barrier and opioid analgesia

  2013cites this paper
• Interrelationship between Heliobacter pylori and P-glycoprotein: potential role in drug resistance and carcinogenicity

  2013cites this paper
• Étude rétrospective sur l'efficacité et la tolérance de l'ivermectine per os chez 27 nourrissons atteints de gale récalcitrante

  2013cites this paper
• In vitro cell models in predicting blood-brain barrier permeability of drugs

  2013cites this paper
• Drug transporters in drug discovery and development

  2013cites this paper
• High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice.

  2013cites this paper
• ADME of Herbal Dietary Supplements

  2012cites this paper
• 5. Transporter Proteins

  2012cites this paper
• Macrocyclic lactones and cellular transport-related drug interactions: a perspective from in vitro assays to nematode control in the field.

  2012cites this paper
• Human liver in vitro models for evaluation of drug metabolism and disposition

  2012cites this paper
• Barriers in the developing brain and Neurotoxicology.

  2012cites this paper
• Les répercussions de l’insuffisance rénale chronique sur le transport des médicaments

  2012cites this paper
• Blood-Brain Barrier and Effectiveness of Therapy Against Brain Tumors

  2012cites this paper
• Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.

  2012cites this paper
• Veterinary pharmacovigilance, from regulation to scientific explanation : case studies of canine MDR1 mutation

  2012cites this paper
• Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

  2012cites this paper
• Treatment of MDR1 Mutant Dogs with Macrocyclic Lactones

  2012cites this paper
• Developmental Expression, Function, and Regulation of Multidrug Resistance in the Mouse Placenta and Fetal Brain

  2012cites this paper
• ABC transportéry: vývoj liekovej rezistencie a iných patologických stavov

  2012cites this paper
• Mechanisms of Chemoresistance in Tumor-Derived Cancer Stem Cells

  2012cites this paper
• Investigating the role of potential genetic markers that can predict risk for steroid refractory inflammatory bowel disease

  2011cites this paper
• Genetic analysis of the xenobiotic resistance‐associated ABC gene subfamilies of the Lepidoptera

  2011cites this paper
• Principles of Chemotherapy

  2011cites this paper
• Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes

  2011cites this paper
• Modulation and absorption of xenobiotics: the synergistic role of CYP450 and P-gp activities in cancer and neurodegenerative disorders.

  2011cites this paper
• ABC transporters, bile acids, and inflammatory stress in liver cancer.

  2011cites this paper
• The effect of the dynamic interplay of P-glycoprotein and cytochrome P450 3A on the portal bioavailability of dual substrates

  2011cites this paper
• Evaluation of drug transporter interactions in drug discovery and development.

  2010cites this paper
• Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects.

  2010cites this paper
• Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.

  2010cites this paper
• Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: Effects of the novel P-glycoprotein inhibitor tariquidar

  2010cites this paper
• Transporter Interactions in the ADME Pathway of Drugs

  2010cites this paper
• Membrane transporters in drug development

  2010cites this paper
• Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.

  2010cites this paper
• The Impact and In Vitro to In Vivo Prediction of Transporter-Based Drug–Drug Interactions in Humans

  2010cites this paper
• Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse.

  2010cites this paper
• Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat.

  2010cites this paper
• Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

  2010cites this paper
• Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion

  2009cites this paper
• The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.

  2009cites this paper
• LIPID-BASED PACLITAXEL AND DOXORUBICIN NANOPARTICLES TO OVERCOME P-GP-MEDIATED DRUG RESISTANCE IN SOLID TUMORS

  2009cites this paper
• Identificationofinterspecies differenceinhepatobiliary transporterstoimprove extrapolationofhumanbiliary secretion

  2009cites this paper
• Drug transporters: Gatekeepers controlling access of xenobiotics to the cellular interior

  2009influential citation
• Theoretical Biology and Medical Modelling

  2009cites this paper
• Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome.

  2009cites this paper
• Current Advances in Modulation of ABC Transporter-mediated Multidrug Resistance in Cancer

  2009cites this paper
• Biological Membranes and Drug Transport

  2009cites this paper
• Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities

  2009cites this paper
• ANTICANCER PROPERTIES OF RESEARCH-GRADE HYDRASTIS CANADENSIS (GOLDENSEAL) AND CHARACTERIZATION OF ITS EFFECT ON THE MDR1 -ENCODED PHOSPHOGLYCOPROTEIN EFFLUX PUMP

  2009cites this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cites this paper
• Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells.

  2009cites this paper
• Investigation of interactions between ABC transporters and their lipid environment - Effect of membrane cholesterol content on the function of human ABCG2 (BCRP/MXR)

  2008cites this paper
• The pharmacogenomics of P-glycoprotein and its role in veterinary medicine.

  2008cites this paper